- Review
 
Navigating the Complexities of Cancer Treatment-Induced Hypertension
- Jose Arriola-Montenegro,
 - John Roth and
 - Maria L. Gonzalez Suarez
 
Cancer therapy-induced hypertension (HTN) is an increasingly recognized complication associated with a wide range of anticancer agents, including vascular endothelial growth factor (VEGF) inhibitors, proteasome inhibitors, tyrosine kinase inhibitors,...

